Ceballos-Garzon, A.
Publications
P270
J. Fungi 2023, 9, 430.
The mortality attributable to candidemia in C. auris is higher than that in other Candida species: Myth or reality?
P251
Microorganisms. 2022, 10, 938.
Prototheca infections and ecology from a One Health perspective.
P249
PLoS One 2022.
CRISPR-Cas9 approach confirms Calcineurin-responsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata.
P247
Int. J. Antimicrob. Agents. 2022.
Head-to-head comparison of CLSI, EUCAST, Etest and Vitek2 results for Candida auris susceptibility testing.
P245
J. Antimicrob. Chemother. 2022, 77, 585–597.
Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.
P211
J. Glob. Infect. Dis. 2020, 12, 16-20.
Persistence of Clonal Candida albicans azole resistant Isolates from a patient with Chronic Mucocutaneous Candidiasis in Colombia.
doi: 10.4103/jgid.jgid_74_19
P210
J. Antimicrob. Chemother. 2020, 75, 1187-1193.
Impact of Calmodulin Inhibition by Fluphenazine on Susceptibility, Biofilm Formation and Pathogenicity of Caspofungin-Resistant Candida glabrata.
doi: 10.1093/jac/dkz565
Thèse
T41.
Etude protéomique et impact de la modulation de la voie de la Calmoduline/Calcineurine chez Candida glabrata résistant à la caspofongine.
Direction : P. Le Pape et C. Parra. Thèse en cotutelle - Université Pontifica Javeriana, Bogota, Colombie. Date de soutenance : 8 février 2021.